NSAIDs should be used cautiously and for the shortest duration necessary, particularly in patients with cardiovascular risk factors, kidney disease, or gastrointestinal conditions
The FDA also issued guidance reinforcing the distinction between FDA-approved medications and compounded alternatives, stating, "The FDA does not verify the safety, effectiveness, or quality of compounded drugs before they are marketed." This highlights the importance of ensuring that patients fully understand the regulatory context of their chosen treatment pathway
The role of prebiotics and probiotics as an adjuvant therapy in children with idiopathic relapsing nephrotic syndrome: A prospective open-label clinical trial
Its important to note that semaglutide is not intended to be a standalone treatment
We invite you to take our AI quiz to discover the best supplement tailored to your unique health goals
The short answer is an unequivocal, absolute yes